Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Thursday, September 30, 2021.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2021 (2021-09-30): -233.03%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-148.47%
RETURN ON EQUITY (ROE) AVG 3Y
-132.15%
RETURN ON EQUITY (ROE) AVG 5Y
-199.83%
RETURN ON EQUITY (ROE) AVG 10Y
-37.05%
RETURN ON EQUITY (ROE) AVG 15Y
-47.68%
RETURN ON EQUITY (ROE) AVG 20Y
-49.92%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Novavax, Inc.
Market Cap
$1.86B
Return on Equity (ROE)
N/A
TTM Avg
-148.47%
3Y Avg
-132.15%
5Y Avg
-199.83%
Market Cap
$1.87B
Return on Equity (ROE)
-15.90%
TTM Avg
-35.70%
3Y Avg
-33.44%
5Y Avg
-75.43%
Market Cap
$1.85B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
Market Cap
$1.84B
Return on Equity (ROE)
-28.45%
TTM Avg
-88.46%
3Y Avg
-128.76%
5Y Avg
-100.86%
Market Cap
$1.89B
Return on Equity (ROE)
-186.63%
TTM Avg
-33.22%
3Y Avg
-16.69%
5Y Avg
-32.64%
Market Cap
$1.83B
Return on Equity (ROE)
4.88%
TTM Avg
4.47%
3Y Avg
6.79%
5Y Avg
5.89%
Market Cap
$1.89B
Return on Equity (ROE)
-40.09%
TTM Avg
4.56%
3Y Avg
-13.84%
5Y Avg
-2.18%
Market Cap
$1.83B
Return on Equity (ROE)
-8.95%
TTM Avg
-23.57%
3Y Avg
-73.07%
5Y Avg
-68.36%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novavax, Inc. (NVAX) | $1.86B | N/A | -148.47% | -132.15% | -199.83% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | -15.90% | -35.70% | -33.44% | -75.43% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -48.43% | -97.59% | -126.46% | -100.04% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | -28.45% | -88.46% | -128.76% | -100.86% |
| Zymeworks Inc. (ZYME)vs › | $1.89B | -186.63% | -33.22% | -16.69% | -32.64% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 4.88% | 4.47% | 6.79% | 5.89% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -40.09% | 4.56% | -13.84% | -2.18% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -8.95% | -23.57% | -73.07% | -68.36% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -8.14% | -6.28% | -6.47% | -2.03% |
ROE
N/A
ROA
-25.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2021-09-30 | -233.03% |
| 2021-06-30 | -127.41% |
| 2021-03-31 | -59.20% |
| 2020-12-31 | -66.69% |
| 2020-09-30 | -256.04% |
| 2020-06-30 | -50.54% |
| 2016-09-30 | -605.94% |
| 2016-06-30 | -243.86% |
| 2016-03-31 | -113.15% |
| 2015-12-31 | -53.62% |
| 2015-09-30 | -29.88% |
| 2015-06-30 | -24.84% |
| 2015-03-31 | -23.39% |
| 2014-12-31 | -36.12% |
| 2014-09-30 | -25.02% |
| 2014-06-30 | -21.66% |
| 2014-03-31 | -29.20% |
| 2013-12-31 | -25.58% |
| 2013-09-30 | -21.22% |
| 2013-06-30 | -54.72% |
| 2013-03-31 | -40.18% |
| 2012-12-31 | -35.53% |
| 2012-09-30 | -39.39% |
| 2012-06-30 | -33.03% |
| 2012-03-31 | -35.43% |
| 2011-12-31 | -35.96% |
| 2011-09-30 | -36.95% |
| 2011-06-30 | -48.54% |
| 2011-03-31 | -59.31% |
| 2010-12-31 | -60.47% |
| 2010-09-30 | -67.39% |
| 2010-06-30 | -73.58% |
| 2010-03-31 | -65.63% |
| 2009-12-31 | -51.53% |
| 2009-09-30 | -52.97% |
| 2009-06-30 | -59.96% |
| 2009-03-31 | -96.95% |
| 2008-12-31 | -79.25% |
| 2008-09-30 | -60.90% |
| 2008-06-30 | -74.78% |
| 2008-03-31 | -61.17% |
| 2007-12-31 | -55.13% |
| 2007-09-30 | -44.09% |
| 2007-06-30 | -34.57% |
| 2007-03-31 | -29.80% |
| 2006-12-31 | -24.54% |
| 2006-09-30 | -10.86% |
| 2006-06-30 | -8.17% |
| 2006-03-31 | -7.13% |
| 2005-12-31 | -22.50% |
| 2005-09-30 | -138.77% |
| 2005-06-30 | -147.36% |
| 2005-03-31 | -121.13% |
| 2004-12-31 | -77.89% |
| 2004-09-30 | -42.98% |
| 2004-06-30 | -83.21% |
| 2004-03-31 | -54.41% |
| 2003-12-31 | -48.06% |
| 2003-09-30 | -150.70% |
| 2003-06-30 | -140.73% |
